Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare professionals and other tertiary sectors. It serves healthcare facilities and private healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-lès-Nancy, France. Equasens Société anonyme operates as a subsidiary of Marque Verte Sante.
Frequently asked questions
What sector does Equasens Société anonyme (EQS) operate in?
Equasens Société anonyme belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Equasens Société anonyme (EQS) current stock price?
As of the latest data, Equasens Société anonyme stock price is €33.20, with a previous close of €33.20.
What is Equasens Société anonyme (EQS) current market capitalization?
Equasens Société anonyme market cap is approximately 499.07 million.
What is Equasens Société anonyme (EQS) Earnings Per Share (EPS)?
The trailing EPS is €2.59, and the forward EPS is €3.43.
What is Equasens Société anonyme (EQS) Price-to-Earnings (P/E) ratio?
Equasens Société anonyme current P/E ratio is 12.82, with a forward P/E of 9.67.
Does Equasens Société anonyme (EQS) pay dividends?
Yes. Equasens Société anonyme pays annual dividends with an annualized yield of 4.22% and an estimated annual payout of €1.40 per share.
When is the next ex-dividend date for Equasens Société anonyme (EQS)?
The next ex-dividend date is scheduled for July 01, 2027.
When is Equasens Société anonyme (EQS) next earnings report?
Equasens Société anonyme is expected to release its next earnings report on June 30, 2026.
What is Equasens Société anonyme (EQS) beta (volatility) score?
Equasens Société anonyme has a beta of 0.568, indicating lower volatility than the overall market.